A total of three differentially hypermethylated genes (CCNE1, PON3, and CCNDBP1) and two differentially hypomethylated genes (DDX43 and CHL1) were selected for the validation based on their β-value and association with CRC as well as other cancers. The gene discussed is CCNDBP1; the disease is cancer.